Background
Young adults with cancer are at increased risk for suicidal ideation. The impact of the patient-oncologist alliance on suicidal ideation has not been examined. This study examined the relationship between the patient-oncologist therapeutic alliance and suicidal ideation in young adults with advanced cancer.
Methods
Young adult patients (age 20-40 years; n=93) with incurable, recurrent, or metastatic cancer were evaluated by trained interviewers. Suicidal ideation was assessed with the Yale Evaluation of Suicidality, dichotomized into a positive and negative score. Predictors included diagnoses of Major Depressive Disorder (MDD) and Post-Traumatic Stress Disorder (PTSD), physical quality of life, social support, and utilization of mental health and supportive care services. The Human Connection Scale, dichotomized into strong (upper third) and weak (lower two-thirds) therapeutic alliance assessed strength of the patients’ perceived oncologist alliance.
Results
22.6% screened positive for suicidal ideation. Patients with a strong therapeutic alliance were at reduced risk for suicidal ideation after controlling for confounding influences of cancer diagnosis, performance status, number of physical symptoms, physical quality of life, MDD, PTSD, and social support. A strong therapeutic alliance was also associated with reduced risk for suicidal ideation after controlling for mental health discussions with healthcare providers and use of mental health interventions.
Conclusions
The patient-oncologist alliance was a robust predictor of suicidal ideation and provided better protection against suicidal ideation than mental health interventions, including psychotropic medications. Oncologists may significantly influence patients’ mental health and may benefit from training and guidance in building strong alliances with their young adult patients.